Inventor
Christophe Claude Parsy
Inventor
Jacou, FR
Overview
Patents· 23 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%
C07DHeterocyclic compounds21%
A61KPreparations for medical, dental or toiletry purposes19%
C07HSugars12%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium8%
B01JChemical or physical processes, e.g. catalysis or colloid chemistry7%
C07CAcyclic or carbocyclic compounds7%
C07KPeptides3%
PatentTitleYear
11,040,975Carbocyclic nucleoside reverse transcriptase inhibitors202110,815,264Nucleotides for the treatment of cancer202010,766,917Nucleotides for the treatment of cancer202010,513,5342'-chloro nucleoside analogs for HCV infection201910,231,986Amino acid phosphoramidate pronucleotides of 2'-cyano, azido and amino nucleosides for the treatment of HCV201910,030,044Nucleotides for the treatment of liver cancer20189,353,100'Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating HCV infections'20169,309,275'3′-deoxy nucleosides for the treatment of HCV'20169,296,778'3′,5′-cyclic phosphate prodrugs for HCV infection'20169,284,307'Macrocyclic serine protease inhibitors'20169,187,496'5,5-fused arylene or heteroarylene hepatitis C virus inhibitors'20159,115,095'Phosphinate ruthenium complexes'20159,109,001'3′,5′-cyclic phosphoramidate prodrugs for HCV infection'20158,993,595'Macrocyclic serine protease inhibitors'20158,765,966'Phosphinate ruthenium complexes'20148,507,460'Substituted 3′,5′-cyclic phosphates of purine nucleotide compounds and pharmaceutical compositions for the treatment of viral infections'20138,481,748'Phosphinate ruthenium complexes'20138,410,313'Phosphinate ruthenium complexes'20138,377,962'Macrocyclic serine protease inhibitors'20138,362,068'5,5-fused arylene or heteroarylene hepatitis C virus inhibitors'20138,362,018'Substituted imidazo[1,2-a]pyrazine compounds useful for the treatment of viral infections'20138,309,737'Phosphinate ruthenium complexes'20128,003,659'Macrocyclic serine protease inhibitors'2011Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2011–2021Based in Jacou, FR· patent location history
2012–2016Patents assigned to IDENIX PHARMACEUTICALS INC (13)· patent assignee history
2012–2016Patents assigned to PARSY CHRISTOPHE CLAUDE (6)· patent assignee history
2012–2016Patents assigned to ALEXANDRE FRANCOIS-RENE (5)· patent assignee history
2012–2016Patents assigned to SURLERAUX DOMINIQUE (5)· patent assignee history
2015–2021Patents assigned to IDENIX PHARMACEUTICALS LLC (10)· patent assignee history
2020Based in Montpellier, FR· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| IDENIX PHARMACEUTICALS INC | 13 | 2012–2016 |
| IDENIX PHARMACEUTICALS LLC | 10 | 2015–2021 |
| PARSY CHRISTOPHE CLAUDEself | 6 | 2012–2016 |
| ALEXANDRE FRANCOIS-RENE | 5 | 2012–2016 |
| SURLERAUX DOMINIQUE | 5 | 2012–2016 |
Locations
| Location | Patents | Span |
|---|---|---|
| Jacou, FR | 22 | 2011–2021 |
| Montpellier, FR | 1 | 2020 |